Unlike traditional dry eye therapies, Tixel irequires no downtime. The entire treatment takes only two minutes, and patients ...

A panelist discusses how the COAT trial demonstrated that twice-daily 0.09% cyclosporine improves multiple signs and symptoms ...

A phase 3 clinical trial investigating ST-100 for the treatment of dry eye disease did not meet its primary endpoint but ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

Myopia is not just a matter of needing glasses or contact lenses,” Gawne said. “The increased axial length of the eye remains ...

The idea that a prolonged interval between diagnosing and treating uveal melanoma can affect prognosis has been at the centre of an active debate.1–5 This issue focuses on a key question for ...

A recent study found that older adults with diabetes who use a GLP-1 drug have double the risk of developing wet age-related ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

A high-level overview of Ocular Therapeutix, Inc. (OCUL) stock. View (OCUL) real-time stock price, chart, news, analysis, analyst reviews and more.

Shares of Krystal Biotech KRYS gained 4.2% on Tuesday after the company announced that it has dosed the first patient in the ...

With overall syphilis rates on the rise, serologic testing for syphilis in patients with uveitis can help prevent permanent vision damage.